Click Here for 5% Off Your First Aladdin Purchase!

2,4-Dichloropyrimidine - 98%, high purity , CAS No.3934-20-1

  • ≥98%
Item Number
D103228
Grouped product items
SKUSizeAvailabilityPrice Qty
D103228-500g
500g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$1,454.90
D103228-5g
5g
In stock
$34.90
D103228-10g
10g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$61.90
D103228-25g
25g
In stock
$99.90
D103228-100g
100g
In stock
$359.90
D103228-250g
250g
In stock
$807.90

Discover 2,4-Dichloropyrimidine by Aladdin Scientific in 98% for only $34.90. Available - in Ligands at Aladdin Scientific. Tags: Halogenated heterocyclic block, Pyrimidines.

Basic Description

Synonyms2,4-Dichloropyrimidine|3934-20-1|2,4-Dichloro-pyrimidine|2,6-Dichloropyrimidine|Pyrimidine, 2,4-dichloro-|2,4-dichlorpyrimidin|MFCD00006061|YV96122OCD|DTXSID9049293|NSC-20212|NSC-37531|NSC-49119|2-CHLOROPYRIMIDIN-4-YL CHLORIDE|Pyrimidine,4-dichloro-|2,4-d
Specifications & Purity98%
Storage TempStore at 2-8°C,Argon charged
Shipped InWet ice
Product Description

2,4-Dichloropyrimidine is a human skin sensitizer. It undergoes effective one-pot, regioselective double Suzuki coupling reaction to yield diarylated pyrimidines

Names and Identifiers

IUPAC Name 2,4-dichloropyrimidine
INCHI InChI=1S/C4H2Cl2N2/c5-3-1-2-7-4(6)8-3/h1-2H
InChi Key BTTNYQZNBZNDOR-UHFFFAOYSA-N
Canonical SMILES C1=CN=C(N=C1Cl)Cl
Isomeric SMILES C1=CN=C(N=C1Cl)Cl
WGK Germany 3
PubChem CID 77531
Molecular Weight 148.98
Beilstein 110911
Reaxy-Rn 110911

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

18 results found

Lot NumberCertificate TypeDateItem
G2412096Certificate of AnalysisMar 08, 2024 D103228
C2429385Certificate of AnalysisMar 08, 2024 D103228
C2429386Certificate of AnalysisMar 08, 2024 D103228
C2429387Certificate of AnalysisMar 08, 2024 D103228
C2412200Certificate of AnalysisFeb 26, 2024 D103228
C2412199Certificate of AnalysisFeb 26, 2024 D103228
F23281156Certificate of AnalysisJul 04, 2023 D103228
F23281157Certificate of AnalysisJul 04, 2023 D103228
F23281158Certificate of AnalysisJul 04, 2023 D103228
F23281159Certificate of AnalysisJul 03, 2023 D103228
G2207083Certificate of AnalysisJul 11, 2022 D103228
I2224150Certificate of AnalysisJun 13, 2022 D103228
I2224141Certificate of AnalysisJun 13, 2022 D103228
I2224125Certificate of AnalysisJun 13, 2022 D103228
I2224123Certificate of AnalysisJun 13, 2022 D103228
I2214122Certificate of AnalysisJun 13, 2022 D103228
G1831122Certificate of AnalysisJun 11, 2022 D103228
G1831121Certificate of AnalysisJun 11, 2022 D103228

more

Chemical and Physical Properties

SolubilitySoluble in water (partly), methanol, chloroform, and ethyl acetate.
Sensitivityair sensitive ,Moisture sensitive
Boil Point(°C)101°C/23mmHg
Melt Point(°C)57-61°C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 3
Reaxy-Rn 110911

Related Documents

References

1. Charles Q Huang,Dimitri E Grigoriadis,Zhengyu Liu,James R McCarthy,John Ramphal,Thomas Webb,Jeffrey P Whitten,Michael Y Xie,Chen Chen.  (2004-04-15)  Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonists..  Bioorganic & medicinal chemistry letters,  14  ((9)): (2083-2086).  [PMID:15080983]
2. Bodo Scheiper,Melanie Bonnekessel,Helga Krause,Alois Fürstner.  (2004-05-22)  Selective iron-catalyzed cross-coupling reactions of grignard reagents with enol triflates, acid chlorides, and dichloroarenes..  The Journal of organic chemistry,  69  ((11)): (3943-3949).  [PMID:15153029]
3. Mark H Norman,Jiawang Zhu,Christopher Fotsch,Yunxin Bo,Ning Chen,Partha Chakrabarti,Elizabeth M Doherty,Narender R Gavva,Nobuko Nishimura,Thomas Nixey,Vassil I Ognyanov,Robert M Rzasa,Markian Stec,Sekhar Surapaneni,Rami Tamir,Vellarkad N Viswanadhan,James J S Treanor.  (2007-06-26)  Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides..  Journal of medicinal chemistry,  50  ((15)): (3497-3514).  [PMID:17585749]
4. D W Roberts,A O Aptula,G Y Patlewicz.  (2011-06-16)  Chemistry-based risk assessment for skin sensitization: quantitative mechanistic modeling for the S(N)Ar domain..  Chemical research in toxicology,  24  ((7)): (1003-1011).  [PMID:21671633]
5. Samantha C Anderson,Scott T Handy.  (2010-08-01)  One-pot Double Suzuki Couplings of Dichloropyrimidines..  Synthesis,  2010  ((16)): (2721-2724).  [PMID:22368305]
6. Suman Rao,Deepak Gurbani,Guangyan Du,Robert A Everley,Christopher M Browne,Apirat Chaikuad,Li Tan,Martin Schröder,Sudershan Gondi,Scott B Ficarro,Taebo Sim,Nam Doo Kim,Matthew J Berberich,Stefan Knapp,Jarrod A Marto,Kenneth D Westover,Peter K Sorger,Nathanael S Gray.  (2019-04-16)  Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome..  Cell chemical biology,  26  ((6)): (818-829).  [PMID:30982749]
7. Xiaohu Deng,Neelakandha S Mani.  (2006-01-18)  An efficient route to 4-aryl-5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine..  Organic letters,  ((2)): (269-272).  [PMID:16408892]
8. Mahbub Alam,Rebekah E Beevers,Tom Ceska,Richard J Davenport,Karen M Dickson,Mara Fortunato,Lewis Gowers,Alan F Haughan,Lynwen A James,Mark W Jones,Natasha Kinsella,Christopher Lowe,Johannes W G Meissner,Anne-Lise Nicolas,Benjamin G Perry,David J Phillips,William R Pitt,Adam Platt,Andrew J Ratcliffe,Andrew Sharpe,Laura J Tait.  (2007-04-27)  Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors..  Bioorganic & medicinal chemistry letters,  17  ((12)): (3463-3467).  [PMID:17459703]

Solution Calculators